Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

NCT00831012 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Dengue Fever

Interventions

BIOLOGICAL: rDEN3delta30/31-7164

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]